No Pharma Money
News & Reports
News July 15, 2019

The Week in Review in Prescription Drug Pricing

By P4ADNow Team

Ugh, drug pricing. Water we going to do about it? We’re floating some ideas.
 
1. Don’t Sell Out Sickle Cell Patients

  • Taxpayers invested hundreds of millions of dollars into a cure for sickle cell disease. Now a drug company could make billions from the drug. — (FierceHealthcare)

2. Program Canceled ?

  • Americans wanted to list drug price ads on TV. Big Pharma and a federal judge said no. — (The New York Times)

3. Tea Leaves

  • Could a closed-door meeting with Trump aides and GOP senators hint at a path forward to slow the roll of Part D price hikes? — (The Hill)

4. Negotiation. The American Way!

  • The president said the U.S. should pay what other nations pay for drugs. Now the focus turns to the administration’s International Pricing Index.— (STAT & Yahoo Finance)

5. California is Not Dreamin’

  • AB824, legislation that would end shady, collusive pay-for-delay deals, is movin’ in real life. — (Twitter)

Stay Connected

Stay informed about the latest campaigns, policy developments, and ways to help lower prescription drug prices.